(Q33390251)

26 July 2017

title

Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas (English)

1 reference

26 July 2017

Sanja Dacic

1

1 reference

26 July 2017

Hannelore Kothmaier

2

1 reference

26 July 2017

Stephanie Land

3

1 reference

26 July 2017

Yongli Shuai

4

1 reference

26 July 2017

Iris Halbwedl

5

1 reference

26 July 2017

Patrizia Morbini

6

1 reference

26 July 2017

Bruno Murer

7

1 reference

26 July 2017

Camilla Comin

8

1 reference

26 July 2017

Françoise Galateau-Salle

9

1 reference

26 July 2017

Funda Demirag

10

1 reference

26 July 2017

Handan Zeren

11

1 reference

26 July 2017

Richard Attanoos

12

1 reference

26 July 2017

Alan Gibbs

13

1 reference

26 July 2017

Philip Cagle

14

1 reference

26 July 2017

Helmut Popper

15

1 reference

26 July 2017

publication date

29 October 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

453

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

627-635

1 reference

Alterations of the p16(INK4) locus in human malignant mesothelial tumors

26 July 2017

cites work

1 reference

12 December 2020

Prognostic factors in mesothelioma

1 reference

12 December 2020

Codeletion of p15 and p16 in primary malignant mesothelioma

1 reference

12 December 2020

Chemotherapy targeting methylthioadenosine phosphorylase (MTAP) deficiency in adult T cell leukemia (ATL).

1 reference

12 December 2020

Malignant pleural disease

1 reference

12 December 2020

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

1 reference

12 December 2020

Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.

1 reference

12 December 2020

Update on the molecular biology of malignant mesothelioma

1 reference

12 December 2020

Cytogenetic and molecular genetic changes in malignant mesothelioma.

1 reference

12 December 2020

Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.

1 reference

12 December 2020

Gene expression profiling of malignant mesothelioma.

1 reference

12 December 2020

Simian virus-40 large-T antigen binds p53 in human mesotheliomas.

1 reference

12 December 2020

A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.

1 reference

12 December 2020

Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.

1 reference

12 December 2020

Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40.

1 reference

12 December 2020

Molecular prognostic markers in malignant mesothelioma

1 reference

12 December 2020

Malignant pleural mesothelioma: current concepts in treatment

1 reference

12 December 2020

Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma

1 reference

12 December 2020

Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas

1 reference

12 December 2020

P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma

1 reference

12 December 2020

EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors

1 reference

12 December 2020

Malignant mesothelioma

1 reference

12 December 2020

The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma

1 reference

12 December 2020

The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions

1 reference

12 December 2020

Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro

1 reference

12 December 2020

Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma

1 reference

12 December 2020

Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience

1 reference

12 December 2020

Molecular biology of malignant mesothelioma: a review

1 reference

12 December 2020

Multimodality approach in management of malignant pleural mesothelioma

1 reference

12 December 2020

10.1007/S00428-008-0689-3

Identifiers

DOI

1 reference

26 July 2017

1 reference